Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F03A7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,444
Award facts
- Contract value 100% obligated
- $10,444.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,444.11 to AmerSourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/ml syringe kits. This is a firm fixed-price contract with an ultimate completion date of January 13, 2026, and represents a non-set-aside award. The contract will be performed at AmerSourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. CIMZIA (certolizumab pegol) is a biologic immunosuppressant medication used to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, indicating this delivery supports the pharmaceutical needs of military healthcare systems and federal medical facilities.
This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the vehicle for AmerSourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The non-set-aside status of this award reflects AmerSourceBergen's capability to compete successfully on a full and open basis for federal pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F03A7?
SPE2DR26F03A7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F03A7 worth?
The government has obligated $10,444 on SPE2DR26F03A7.
Is contract SPE2DR26F03A7 an order under another contract?
Yes. SPE2DR26F03A7 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03A7 competed?
The extent of competition for SPE2DR26F03A7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award